Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of tic-disorders].

Veit Roessner1, Tobias Banaschewski, Aribert Rothenberger

  • 1Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Universität Göttingen. vroessn@gwdg.de

Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
|November 30, 2004
PubMed
Summary

Novel antipsychotics like risperidone and behavior therapy offer new hope for treating tic disorders in children and adolescents. These approaches show promising results and may become standard care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical activity and psychopathology: are long-term developmental trajectories of physical activity in children and adolescents associated with trajectories of general mental health problems and of attention-deficit hyperactivity (ADHD) symptoms?

European child & adolescent psychiatry·2024
Same author

Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Is only-child status associated with a higher blood pressure in adolescence? An observational study.

European journal of pediatrics·2023
Same author

Co-Occurrence of Tic Disorders and Attention-Deficit/Hyperactivity Disorder-Does It Reflect a Common Neurobiological Background?

Biomedicines·2022
Same author

Physical activity and the development of general mental health problems or attention-deficit hyperactivity disorder (ADHD) symptoms in children and adolescents: A cross-lagged panel analysis of long-term follow-up epidemiological data.

Frontiers in behavioral neuroscience·2022
Same author

European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

European child & adolescent psychiatry·2021

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Context:

  • Tic disorders affect children and adolescents, with recent advancements in therapeutic strategies.
  • Novel neuroleptics and advanced behavioral techniques offer potential new treatments.

Purpose:

  • To review the current state of therapeutic approaches for tic disorders.
  • To explore recent progress in pharmacological and behavioral interventions.

Summary:

  • Clonidine and risperidone (a novel antipsychotic) have the strongest empirical support for drug treatment globally.
  • Benzamides are well-established in Europe, and behavior therapy is increasingly supported by empirical data.
  • Risperidone is a potential first-line drug, and behavior therapy may be integrated into multimodal treatment programs.

Impact:

  • This review provides an updated perspective on effective tic disorder treatments.
  • Highlights the growing evidence for risperidone and behavior therapy in managing tic disorders.
  • Informs clinical practice towards more effective, multimodal treatment strategies for pediatric tic disorders.

Related Experiment Videos